Kaul I, Claxton A, Sauder C, Patel T, et al. Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial. Am J Psychiatry 2026 Feb 4:appiajp20241186. doi: 10.1176/appi.ajp.20241186.
PMID: 41634905